FDA pulls generics labeling proposed ruleThe FDA has withdrawn a 2013 proposed rule that would have allowed generic drug makers to independently update drug labels. Mayne Pharma gets FDA nod for TolsuraMayne Pharma's Tolsura provides a new formulation of itraconazole for fungal infections. FDA issues new guidances to advance biosimilars The Food and Drug Administration said it expects to focus on preventing potentially anti-competitive practices for biosimilar drugs. Lupin introduces generic Rapaflo Lupin rolls out generic Rapaflo, which had a market value of about $198.5 million. FDA gives Lupin's generic Eliquis tentative approval The FDA has given tentative clearance for Lupin's generic Eliquis, which had a market value of about $6.4 billion. Hikma launches generic Onfi Hikma is offering clobazam oral suspension and clobazam tablets, which had a market value of $260 million and $601 million respectively. FDA issues draft guidance to ensure safety of compounded drugs The FDA's revised draft guidance aims to protect patients from contaminated or substandard compounded drugs. Rite Aid Foundation brings Prescription Drug Safety Initiative to Scranton The Rite Aid Foundation's efforts to help address adolescent drug abuse and misuse will bring the Prescription Drug Safety program to Scranton, Pa.-area high schools. HFAP unveils compounding pharmacy certification HFAP's compounding pharmacy certification program ensures high standards of quality. Sun Pharma gets FDA green light for generic Ganirelix The Food and Drug Administration has cleared Sun Pharma's generic Ganirelix, which had a market value of about $67 million, according to IQVIA data. First Previous 29 30 31 32 33 Next Last
